Skip to main content
SpringerLink
Log in

Can we afford to ignore missing data in cost-effectiveness analyses?

  • Editorial
  • Published:
The European Journal of Health Economics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Munro, J., Nicholl, J., Brazier, J., Davey, R., Cochrane, T.: Cost effectiveness of a community based exercise programme in over 65 year olds: cluster randomised trial. J Epidemiol Community Health 58, 1004–1010 (2004)

    Article  Google Scholar 

  2. Harris, A., Gospodarevskaya, E., Ritter, A.: A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting. Pharmacoeconomics 23, 77–91 (2005)

    Article  Google Scholar 

  3. Rivero-Arias, O., Campbell, H., Gray, A., Fairbank, J., Frost, H., Wilson-MacDonald, J.: Surgical stabilisation of the spine compared with a programme of intensive rehabilitation for the management of patients with chronic low back pain: cost utility analysis based on a randomised controlled trial. BMJ 330, 1239–1243 (2005)

    Article  Google Scholar 

  4. Billingham, L.J., Bathers, S., Burton, A., Bryan, S., Cullen, M.H.: Patterns, costs and cost-effectiveness of care in a trial of chemotherapy for advanced non-small cell lung cancer. Lung Cancer 37, 219–225 (2002)

    Article  Google Scholar 

  5. Wonderling, D., Vickers, A., Grieve, R., McCarney, R.: Cost effectiveness analysis of a randomised trial of acupuncture for chronic headache in primary care. BMJ 328, 747 (2004)

    Article  Google Scholar 

  6. Drummond, M., Jefferson, T.: Guidelines for authors and peer reviewers of economic submissions to the BMJ. BMJ 313, 275–283 (1996)

    Google Scholar 

  7. Jefferson, T., Smith, R., Yee, Y., Drummond, M., Pratt, M., Gale, R.: Evaluating the BMJ guidelines for economic submissions: prospective audit of economic submissions to BMJ and The Lancet. JAMA 280, 275–277 (1998)

    Article  Google Scholar 

  8. Burton, A., Altman, D.G.: Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines. Br J Cancer 91, 4–8 (2004)

    Article  Google Scholar 

  9. Wood, A.M., White, I.R., Thompson, S.G.: Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals. Clin Trials 1, 368–376 (2004)

    Article  Google Scholar 

  10. Little, R.J.A., Rubin, D.B.: Statistical analysis with missing data. Wiley, New York (1987)

    Google Scholar 

  11. Rubin, D.B.: Multiple imputation for nonresponse in surveys. Wiley, New York (1987)

    Google Scholar 

  12. Schafer, J.L.: Analysis of incomplete multivariate data. Chapman & Hall, New York (1997)

    Google Scholar 

  13. Harrell, F.E.: Regression modeling strategies with applications to linear models, logistic regression, and survival analysis. Springer, New York (2001)

    Google Scholar 

  14. van Buuren, S., Boshuizen, H.C., Knook, D.L.: Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 18, 681–694 (1999)

    Article  Google Scholar 

  15. Little, R.J.A., Rubin, D.B.: Statistical analysis with missing data, 2nd edn. Wiley, New York (2002)

    Google Scholar 

  16. Briggs, A., Clark, T., Wolstenholme, J., Clarke, P.: Missing... presumed at random: cost-analysis of incomplete data. Health Econ 12, 377–392 (2003)

    Article  Google Scholar 

  17. Yu, L.M., Burton, A., Rivero-Arias, O.: Evaluation of software for multiple imputation of semi-continuous data. Stat Methods Med Res 16, 243–258 (2007)

    Article  Google Scholar 

  18. Royston, P.: Multiple imputation of missing values. Stata J 4, 227–241 (2004)

    Google Scholar 

  19. Royston, P.: Multiple imputation of missing values: update. Stata J 5, 188–201 (2005)

    Google Scholar 

  20. Royston, P.: Multiple imputation of missing values: update of ice. Stata J 5, 527–536 (2005)

    Google Scholar 

  21. van Buuren, S., Oudshoorn, C.G.M.: Mice: multivariate imputation by chained equations library. R Stat Softw Ver 1(13), 1 (2005)

    Google Scholar 

  22. Kenward, M.G., Carpenter, J.: Multiple imputation: current perspectives. Stat Methods Med Res 16, 199–218 (2007)

    Article  Google Scholar 

  23. Burton, A., Billingham, L., Bryan, S.: Cost-effectiveness in clinical trials: using multiple imputation to deal with incomplete cost data. Clin Trials 4, 154–161 (2007)

    Article  Google Scholar 

  24. UK BEAM Trial Team: United Kingdom back pain exercise and manipulation (UK BEAM) randomised trial: cost effectiveness of physical treatments for back pain in primary care. BMJ 329, 1381–1385 (2004)

    Article  Google Scholar 

  25. Cullen, M.H., Billingham, L.J., Woodroffe, C.M., Chetiyawardana, A.D., Gower, N.H., Joshi, R., Ferry, D.R., Rudd, R.M., Spiro, S.G., Cook, J.E., Trask, C., Bessell, E., Connolly, C.K., Tobias, J., Souhami, R.L.: Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life. J Clin Oncol 17, 3188–3194 (1999)

    Google Scholar 

  26. Manca, A., Palmer, S.: Handling missing data in patient-level cost-effectiveness analysis alongside randomised clinical trials. Appl Health Econ Health Policy 4, 65–75 (2005)

    Article  Google Scholar 

  27. Bang, H., Tsiatis, A.: Estimating medical costs with censored data. Biometrika 87, 329–343 (2000)

    Article  Google Scholar 

  28. Royston, P.: Multiple imputation of missing values: further update of ice, with an emphasis on interval censoring. Stata J 7, 445–464 (2007)

    Google Scholar 

Download references

Acknowledgements

We are extremely grateful to Dr Michael Cullen, Consultant and Honorary Reader in Medical Oncology, Queen Elizabeth Hospital, Birmingham, UK, and Sarah Bathers, Assistant Director, Cancer Research UK Clinical Trials Unit, Birmingham, UK, for use of the data.

Author information

Authors and Affiliations

  1. Warwick Clinical Trials Unit, University of Warwick, Coventry, Gibbet Hill Road, Coventry, CV4 7AL, UK

    Andrea Marshall

  2. Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK

    Lucinda J. Billingham

  3. Health Economics Facility, University of Birmingham, Birmingham, UK

    Stirling Bryan

Authors
  1. Andrea Marshall
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lucinda J. Billingham
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stirling Bryan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrea Marshall.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marshall, A., Billingham, L.J. & Bryan, S. Can we afford to ignore missing data in cost-effectiveness analyses?. Eur J Health Econ 10, 1–3 (2009). https://doi.org/10.1007/s10198-008-0129-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10198-008-0129-y

Search

Navigation